Robert Wieder
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Fibroblast Growth Factor Research 16
- Retinoids in leukemia and cellular processes 5
- Wnt/β-catenin signaling in development and cancer 5
- Oncology 23
- Cancer Cells and Metastasis 11
- Cancer-related Molecular Pathways 6
- Co-authors
- Reju Korah (12 shared papers)Qin Wang (7 shared papers)Sylvia Christakos (2 shared papers)Michael B. Shimkin (7 shared papers)Eyal Fenig (8 shared papers)Joachim Yahalom (8 shared papers)Nabil R. Adam (9 shared papers)Huisheng Wang (6 shared papers)
- Journals
- Breast Cancer Research and Treatment (6 papers)Cancers (6 papers)Blood (2 papers)Pain Medicine (2 papers)Investigational New Drugs (2 papers)
- Partner nations
- United StatesIsraelNetherlands
In The Last Decade
Robert Wieder
66 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 319
- Oncology 520
- Immunology and Allergy 81
- Molecular Biology 891
- Cell Biology 211
Countries citing papers authored by Robert Wieder
This map shows the geographic impact of Robert Wieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wieder more than expected).
Fields of papers citing papers by Robert Wieder
This network shows the impact of papers produced by Robert Wieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wieder. The network helps show where Robert Wieder may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Wieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 147 | |
| 2 | 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. | 2000 | 136 |
| 3 | 2004 | 113 | |
| 4 | 2001 | 74 | |
| 5 | Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events. | 1997 | 69 |
| 6 | 1998 | 63 | |
| 7 | 2010 | 59 | |
| 8 | 2018 | 56 | |
| 9 | Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells. | 2000 | 52 |
| 10 | 2004 | 48 | |
| 11 | 1999 | 45 | |
| 12 | 1978 | 45 | |
| 13 | Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. | 1997 | 45 |
| 14 | 2004 | 36 | |
| 15 | Relation of thymidine index to pulmonary tumor response in mice receiving urethan and other carcinogens. | 1969 | 35 |
| 16 | 2005 | 34 | |
| 17 | 1968 | 34 | |
| 18 | 2023 | 33 | |
| 19 | 1997 | 33 | |
| 20 | Lung tumor response in strain A mice as a quantitative bioassay of carcinogenic activity of some carbamates and aziridines. | 1969 | 33 |
About Robert Wieder
Robert Wieder is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Cell Biology, having authored 66 papers that have together received 1.7k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (16 papers), Cancer Cells and Metastasis (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), Cancer-related Molecular Pathways (6 papers), Retinoids in leukemia and cellular processes (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Breast Cancer Treatment Studies (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). The work is most often cited by research in Cancer Research (319 citations), Oncology (520 citations), Immunology and Allergy (81 citations), Molecular Biology (891 citations) and Cell Biology (211 citations). Robert Wieder has collaborated with scholars based in United States, Israel and Netherlands. Frequent co-authors include Reju Korah, Qin Wang, Sylvia Christakos, Michael B. Shimkin, Eyal Fenig, Joachim Yahalom, Nabil R. Adam, Huisheng Wang, Wen Yang and Janice Gabrilove. Their work appears in journals such as Breast Cancer Research and Treatment, Cancers, Blood, Pain Medicine and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.